Crossover Versus Parallel Designs: Dose-Escalation Design Comparisons for First-In-Human Studies

By Yan Zhiwu   Hosmane Balakrishna   Locke Charles  

Journal of Biopharmaceutical Statistics, Vol. 23, Iss. 4, 2013-07 ,pp. : 804-817

Taylor & Francis Ltd

Access to resources Recommend Favorite

Cross-over studies of chronic resistant depression

By Keller M.   Zucker M.E.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 198-199

Elsevier

Access to resources Recommend Favorite

Average Bioequivalence for Two-Sequence Two-Period Crossover Design with Incomplete Data

By Lee Jae-Young  

Journal of Biopharmaceutical Statistics, Vol. 15, Iss. 5, 2005-01 ,pp. : 857-867

Taylor & Francis Ltd

Access to resources Recommend Favorite

Hypothesis Testing and Estimation in Ordinal Data Under a Simple Crossover Design

By Lui Kung-Jong  

Journal of Biopharmaceutical Statistics, Vol. 22, Iss. 6, 2012-11 ,pp. : 1137-1147

Taylor & Francis Ltd

Access to resources Recommend Favorite

A Note on Sample Size Determination for Bioequivalence Studies with Higher-Order Crossover Designs

By Chen Keh-Wei   Chow Shein-Chung   Li Gang  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 25, Iss. 6, 1997-12 ,pp. : 753-765

Springer Publishing Company

Access to resources Recommend Favorite